Nigerian Physicians caution against abuse of diabetes drug

 Physicians have cautioned Nigerians against the abuse and misuse of diabetes medication, noting that those using a particular diabetes drug ‘semaglutide’ – an antidiabetic medication used for the treatment of type 2 diabetes-  for weight loss without consulting qualified health experts are endangered.

 

According to experts, semaglutide help lowers blood sugar levels and regulates insulin, which is crucial for people with Type 2 diabetes.  It also imitates a hormone called glucagon-like peptide-1 that is naturally produced in the intestines by limiting appetite and as a result of this, people with obesity and accompanying health concerns have lost weight while taking it. This has caused an overwhelming demand for the drug for weight loss.

 

 

 

The physicians, a Professor of Endocrinology, Christian Okafor, and Consultant Endocrinologist, Dr. Oluwarotimi Olopade noted that obesity is a disease that needs to be treated medically.

 

Read Also: Diabetes: African Traditional Foods Consumption recommended

 

Prof. Christian Okafor stated that in as much the drug has been approved for obesity, it is important to stress that it still undergoing post-market surveillance saying “when people throw caution to the wind and begin to use it anyhow, then they might be exposing patients to unnecessary risks.”

He said, “Everybody knows that it is the responsibility of a doctor to give prescriptions to a patient. We know that our society is one where such boundaries are not respected and people do all sorts of things until they get into trouble.

“This is a drug that has been recently approved for the management of diabetes and weight loss That is not a license for people who are not health practitioners to begin to prescribe the drug so it is for doctors to make the accurate prescription because every drug has side effects and adverse reactions and so forth so the right thing should be done.

“The craze about maintaining your shape should not make people who are not qualified begin to make prescriptions unnecessarily.”

 

In 2017, the United States Food and Drug Administration approved semaglutide as an injectable medication for the treatment of diabetes. 2021 saw FDA approve Wegovy, which has a higher dose of the active ingredient semaglutide to treat obesity.

However, the drug has become a popular weight loss fad with even Elon Musk, the Chief Executive Officer of Twitter attributing his weight loss to the use of the drug in a tweet.

Dr. Olopade stressed that the dosage of the medication for persons with diabetes and for those seeking to lose weight is also different, hence only a health practitioner can rightly know how to give the right prescriptions for the drug.

According to the experts, the unguided use of the drug, mainly used for the management of diabetes has now become the new fad for beauty saloons’ in the weight loss business, warning that using the drug without the guidance of the right health expert could be dangerous.

They also bemoaned the availability of the drug in the market, as such medication should not be easily procured by non-medically certified outlets that are now using it for weight loss.

 

 

 

Healthwise/S.S